Canada and Alberta governments to invest in Entos R&D facility
The facility will develop and manufacture the Entos Fusogenix PLV drug delivery platform.
Mimotopes Early R&D projects
Incyte and Genesis collaborate on small-molecule medicines
Basilea wins CARB-X grant for new antibody development
Bayer and Broad Institute extend cancer therapy development programme
Prelude and AbCellera jump on the ADC train with partnership
Gilead and Assembly Biosciences partner to develop antiviral therapies
Researchers publish early results with new interleukin-targeting antibody
SK bioscience and Doherty Institute partner on flu vaccine research
